Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2023 May 15;38(1):2205042. doi: 10.1080/14756366.2023.2205042

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2023 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group.

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The terms on which this article has been published allow the posting of the Accepted Manuscript in a repository by the author(s) or with their consent.

PMC Copyright notice

Figure 10. — The Venn diagram summarises the anti-proliferative (anti-skin cancer), antioxidant, and tyrosinase inhibitory effects of the 25 compounds. Dual-acting compounds were identified with noteworthy anti-proliferative and antioxidant activity (P22, P23, P24, and P25); anti-proliferative and anti-tyrosinase activity (P12, P14, P17, and P18); and antioxidant and anti-tyrosinase activity (P21). Some tested compounds exhibited only a single noteworthy activity: antioxidant (P6); anti-tyrosinase (P4, P8, and P19), and/or anti-skin-cancer (P3, P9, and P19).